NextCure Provides Business Update and Reports First Quarter 2022 Financial ResultsGlobeNewsWire • 05/05/22
NextCure and the National Cancer Institute Announce Preclinical Data in Journal of Clinical InvestigationGlobeNewsWire • 04/19/22
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 03/03/22
NextCure and Collaborators Provide Data on Targets in Development at American Society of Hematology Annual MeetingGlobeNewsWire • 12/13/21
NextCure to Present at Piper Sandler 33rd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/22/21
NextCure and Collaborators Provide Clinical and Research Updates on NC318 and NC410 Candidates at Society for Immunotherapy of Cancer Annual MeetingGlobeNewsWire • 11/13/21
NextCure Reports Third Quarter 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 11/04/21
NextCure Announces Presentations on Targets in Development by Collaborators at American Society of Hematology Annual MeetingGlobeNewsWire • 11/04/21
NextCure to Give Three Presentations at Society for Immunotherapy of Cancer Annual MeetingGlobeNewsWire • 10/01/21
NextCure to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/07/21
NextCure to Present at the 19th Annual Morgan Stanley Global Healthcare ConferenceGlobeNewsWire • 09/02/21
NextCure's Immunomedicine NC410 Shows Promising Anti-Cancer Activity In Preclinical StudiesBenzinga • 06/22/21
NextCure and Collaborators Publish Preclinical Data on Novel Immunomedicine NC410GlobeNewsWire • 06/21/21